Science Explorer Back to mapMap
Discussion
Researcher · Molecular Networks (Germany) · Germany

Bruno Bienfait

Bruno Bienfait publishes mostly in Molecular Biology, Computational Theory and Mathematics and Spectroscopy, on topics such as Computational Drug Discovery Methods, Protein Kinase Regulation and GTPase Signaling and Analytical Chemistry and Chromatography.

OpenAlex
World rank
#1,612,940
of 7,710,434 ranked researchers
Rank in Germany
#79,532
of 364,343
Works
47
Citations
1.6k
Citations per work
33.0
h-index
17
i10-index 20Top 42% in Molecular Biology
Bruno Bienfait

What does Bruno Bienfait research?

Bruno Bienfait's work is mostly in Biochemistry, Genetics and Molecular Biology (20%), Computer Science (14%), Chemistry (13%).

Everything else: 20 works · 43.3% of their workPhysical Sciences: 13 works · 27.0% of their workComputer Science: 7 works · 14.4% of their workComputational Theory and Mathematics: 7 works · 14.4% of their workChemistry: 6 works · 12.6% of their workOrganic Chemistry: 3 works · 6.3% of their workSpectroscopy: 3 works · 6.3% of their workLife Sciences: 11 works · 24.3% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 19.8% of their workMolecular Biology: 9 works · 19.8% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 4.5% of their workPharmacology: 2 works · 4.5% of their workHealth Sciences: 3 works · 5.4% of their workMedicine: 3 works · 5.4% of their workSurgery: 3 works · 5.4% of their workTHEIR WORKBruno Bienfait47works
Life Sciences24%Physical Sciences27%Health Sciences5%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2043.3%
    1. Computer Science714.4%
    2. Chemistry612.6%
    1. Biochemistry, Genetics and Molecular Biology919.8%
    2. Pharmacology, Toxicology and Pharmaceutics24.5%
    1. Medicine35.4%
  1. 1Molecular Biology20% of their works
  2. 2Computational Theory and Mathematics14% of their works
  3. 3Spectroscopy6% of their works
  4. 4Organic Chemistry6% of their works
  5. 5Surgery5% of their works
  6. 6Pharmacology4% of their works

Research topics

Which keywords describe Bruno Bienfait's research?

The keywords of their largest research topics: Molecular Docking, Virtual Screening, Protein Kinases, Ras Signaling, Chiral Separation, Drug Discovery, Liquid Chromatography and Animal Research Reporting.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Molecular Docking161 topic
  2. Virtual Screening161 topic
  3. Protein Kinases81 topic
  4. Ras Signaling81 topic
  5. Chiral Separation51 topic
  6. Drug Discovery52 topics
  7. Liquid Chromatography51 topic
  8. ARRIVE Guidelines41 topic
  9. Animal Research Reporting41 topic
  10. Drug-Induced Liver Injury31 topic
  11. Foldamers31 topic
  12. Hepatotoxicity31 topic
  13. Peptide Synthesis31 topic
  14. Crystal Structure21 topic
  15. G-Protein-Coupled Receptors21 topic
  16. Protein21 topic
  17. Structure21 topic

Where does Bruno Bienfait work?

Bruno Bienfait's main affiliation in the publication record is Molecular Networks (Germany), Germany.

How many publications and citations does Bruno Bienfait have?

OpenAlex counts 47 works and 1,551 citations for Bruno Bienfait, an h-index of 17, ranking #1,612,940 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Bruno Bienfait. Posts are plain text and can be reported.